Michel Dib

Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis

Denise A. Figlewicz, Aldis Krizus, Maria‐Grazia Martinoli et al. · Human Molecular Genetics · 1994 · 464 citations

Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients

Odile Spreux‐Varoquaux, Gilbert Bensimon, Lucette Lacomblez et al. · Journal of the Neurological Sciences · 2002 · 276 citations

Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Neurophysiology +9

A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis

Claude Desnuelle, Michel Dib, Catherine Garrel et al. · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · 2001 · 259 citations

Annual Rate and Predictors of Conversion to Dementia in Subjects Presenting Mild Cognitive Impairment Criteria Defined according to a Population-Based Study

Hélène Amieva, Luc Letenneur, Jean‐François Dartigues et al. · Dementia and Geriatric Cognitive Disorders · 2004 · 185 citations

Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes

Ahcène Hameg, Franck Baylé, Philippe Nuss et al. · Biochemical Pharmacology · 2003 · 185 citations · Full text

Human Recombinant Dopamine, Anxiolytic Antipsychotic Drug, Psychoactive Drug +12